Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 296

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

ESC Council on hypertension position document on the management of hypertensive emergencies

Open access
van den Born, Bert-Jan H, Lip, Gregory Y H, Brguljan-Hitij, Jana, Cremer, Antoine, Segura, Julian, Morales, Enrique, Mahfoud, Felix, Amraoui, Fouad, Persu, Alexandre, Kahan, Thomas, Agabiti Rosei, Enrico, de Simone, Giovanni, Gosse, Philippe, Williams, Bryan · 2019 · European Heart Journal - Cardiovascular Pharmacotherapy

Abstract

Hypertensive emergencies are those situations where very high blood pressure (BP) values are associated with acute organ damage, and therefore, require immediate, but careful, BP reduction. The type of acute organ damage is the principal determinant of: (i) the drug of choice, (ii) the target BP, and (iii) the timeframe in which BP should be lowered. Key target organs are the heart, retina, brain, kidneys, and large arteries. Patients who lack acute hypertension-mediated end organ damage do not have a hypertensive emergency and can usually be treated with oral BP-lowering agents and usually discharged after a brief period of observation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ehjcvp/pvy032

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 22

  1. van den Born, 2007, The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension, Am J Hypertens, 20, 900, 10.1016/j.amjhyper.2007.02.018 · doi:10.1016/j.amjhyper.2007.02.018
  2. Martin, 2004, Hypertensive crisis profile. Prevalence and clinical presentation, Arq Bras Cardiol, 83, 131
  3. Lohmeier, 1979, Hypertensive and renal effects of chronic low level intrarenal angiotensin infusion in the dog, Circ Res, 44, 154, 10.1161/01.RES.44.2.154 · doi:10.1161/01.res.44.2.154
  4. Mohring, 1978, Plasma vasopressin concentrations and effects of vasopressin antiserum on blood pressure in rats with malignant two-kidney Goldblatt hypertension, Circ Res, 42, 17, 10.1161/01.RES.42.1.17 · doi:10.1161/01.res.42.1.17
  5. McGregor, 1986, Retinal changes in malignant hypertension, Br Med J (Clin Res Ed), 292, 233, 10.1136/bmj.292.6515.233 · doi:10.1136/bmj.292.6515.233
  6. Lip, 2001, A cross-sectional, diurnal, and follow-up study of platelet activation and endothelial dysfunction in malignant phase hypertension, Am J Hypertens, 14, 823, 10.1016/S0895-7061(01)02045-3 · doi:10.1016/s0895-7061(01)02045-3
  7. van den Born, 2008, Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension, Hypertension, 51, 862, 10.1161/HYPERTENSIONAHA.107.103127 · doi:10.1161/hypertensionaha.107.103127
  8. Sforza, 2017, Diagnostic performance of multi-organ ultrasound with pocket-sized device in the management of acute dyspnea, Cardiovasc Ultrasound, 15, 16., 10.1186/s12947-017-0105-8 · doi:10.1186/s12947-017-0105-8
  9. Ledingham, 1979, Cerebral complications in the treatment of accelerated hypertension, Q J Med, 48, 25, 10.1093/oxfordjournals.qjmed.a067564 · doi:10.1093/oxfordjournals.qjmed.a067564
  10. Haas, 1983, Death from cerebral hypoperfusion during nitroprusside treatment of acute angiotensin-dependent hypertension, Am J Med, 75, 1071, 10.1016/0002-9343(83)90891-4 · doi:10.1016/0002-9343(83)90891-4
  11. Clifton, 1989, Intravenous nicardipine in severe systemic hypertension, Am J Cardiol, 64, 16H, 10.1016/0002-9149(89)90975-2 · doi:10.1016/0002-9149(89)90975-2
  12. Hirschl, 1997, Safety and efficacy of urapidil and sodium nitroprusside in the treatment of hypertensive emergencies, Intensive Care Med, 23, 885, 10.1007/s001340050426 · doi:10.1007/s001340050426
  13. Wilson, 1983, Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies, Am J Med, 75, 95, 10.1016/0002-9343(83)90141-9 · doi:10.1016/0002-9343(83)90141-9
  14. Shusterman, 1993, Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function, Am J Med, 95, 161, 10.1016/0002-9343(93)90256-O · doi:10.1016/0002-9343(93)90256-o
  15. Pollack, 2009, Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension, Ann Emerg Med, 53, 329, 10.1016/j.annemergmed.2008.04.025 · DOI
  16. Immink, 2008, Cerebral hemodynamics during treatment with sodium nitroprusside versus labetalol in malignant hypertension, Hypertension, 52, 236, 10.1161/HYPERTENSIONAHA.108.110395 · doi:10.1161/hypertensionaha.108.110395
  17. Marx, 1979, Labetalol infusion in acute myocardial infarction with systemic hypertension, Br J Clin Pharmacol, 8, 233S, 10.1111/j.1365-2125.1979.tb04787.x · doi:10.1111/j.1365-2125.1979.tb04787.x
  18. Chiariello, 1976, Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction, Circulation, 54, 766, 10.1161/01.CIR.54.5.766 · doi:10.1161/01.cir.54.5.766
  19. Mann, 1978, Effect of nitroprusside on regional myocardial blood flow in coronary artery disease. Results in 25 patients and comparison with nitroglycerin, Circulation, 57, 732, 10.1161/01.CIR.57.4.732 · doi:10.1161/01.cir.57.4.732
  20. Schreiber, 1998, The nitura study–effect of nitroglycerin or urapidil on hemodynamic, metabolic and respiratory parameters in hypertensive patients with pulmonary edema, Intensive Care Med, 24, 557, 10.1007/s001340050615 · doi:10.1007/s001340050615
  21. Sheaves, 1995, The dangers of unopposed beta-adrenergic blockade in phaeochromocytoma, Postgrad Med J, 71, 58, 10.1136/pgmj.71.831.58-a · doi:10.1136/pgmj.71.831.58-a
  22. Tauzin-Fin, 2004, Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma, Br J Anaesth, 92, 512, 10.1093/bja/aeh083 · doi:10.1093/bja/aeh083

Cited by

See all 296

Metadata

Authors
van den Born, B.-J. H., Lip, G. Y. H., Brguljan-Hitij, J., Cremer, A., Segura, J., Morales, E., Mahfoud, F., Amraoui, F., Persu, A., Kahan, T., Agabiti Rosei, E., de Simone, G., Gosse, P., & Williams, B.
Venue
European Heart Journal - Cardiovascular Pharmacotherapy
Published
2018-08-25
Volume
5
Issue
1
Pages
37-46
ISSN
  • 2055-6837 (ISSN-L)
  • 2055-6845
OpenAlex
W2888027923
Cited by
296
References
63
FWCI
16.00
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.